Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. Academic Article uri icon

Overview

publication date

  • June 28, 2023

Research

keywords

  • Crohn Disease
  • Helicobacter pylori
  • Lymphoma, B-Cell, Marginal Zone
  • Stomach Neoplasms

Identity

Digital Object Identifier (DOI)

  • 10.1097/DAD.0000000000002470

PubMed ID

  • 37377200